274 related articles for article (PubMed ID: 25816057)
21. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation.
Lim JY; Park SJ; Hwang HY; Park EJ; Nam JH; Kim J; Park SI
J Mol Cell Cardiol; 2005 Oct; 39(4):627-36. PubMed ID: 16125722
[TBL] [Abstract][Full Text] [Related]
22. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
23. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
24. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
[TBL] [Abstract][Full Text] [Related]
26. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
[TBL] [Abstract][Full Text] [Related]
27. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
[TBL] [Abstract][Full Text] [Related]
28. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
29. Effect of SKF‑96365 on cardiomyocyte hypertrophy induced by angiotensin II.
Cheng H; Li J; Wu Q; Zheng X; Gao Y; Yang Q; Sun N; He M; Zhou Y
Mol Med Rep; 2020 Feb; 21(2):806-814. PubMed ID: 31974621
[TBL] [Abstract][Full Text] [Related]
30. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
[TBL] [Abstract][Full Text] [Related]
31. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
32. Icariin inhibits isoproterenol-induced cardiomyocyte hypertropic injury through activating autophagy via the AMPK/mTOR signaling pathway.
Hu L; Wang Z; Li H; Wei J; Tang F; Wang Q; Wang J; Zhang X; Zhang Q
Biochem Biophys Res Commun; 2022 Feb; 593():65-72. PubMed ID: 35063771
[TBL] [Abstract][Full Text] [Related]
33. Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
Jiang Q; Lu M; Li J; Zhu Z
Cardiovasc Ther; 2021; 2021():5554569. PubMed ID: 34257705
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
35. G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.
Pei H; Wang W; Zhao D; Su H; Su G; Zhao Z
Int J Biol Sci; 2019; 15(1):81-92. PubMed ID: 30662349
[TBL] [Abstract][Full Text] [Related]
36. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
Wu Y; Wang BX; Guo YY; Wang YQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):284-8. PubMed ID: 26387199
[TBL] [Abstract][Full Text] [Related]
37. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.
Cao T; Gao Z; Gu L; Chen M; Yang B; Cao K; Huang H; Li M
PLoS One; 2014; 9(8):e103793. PubMed ID: 25099270
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
39. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
[TBL] [Abstract][Full Text] [Related]
40. Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways.
Zhao Z; Liu H; Guo D
Braz J Med Biol Res; 2020; 53(2):e8793. PubMed ID: 31994601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
